164 related articles for article (PubMed ID: 16670338)
1. Control of metastasized pancreatic carcinomas in SCID/beige mice with human IL-2/TKD-activated NK cells.
Stangl S; Wortmann A; Guertler U; Multhoff G
J Immunol; 2006 May; 176(10):6270-6. PubMed ID: 16670338
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells.
Moser C; Schmidbauer C; Gürtler U; Gross C; Gehrmann M; Thonigs G; Pfister K; Multhoff G
Cell Stress Chaperones; 2002 Oct; 7(4):365-73. PubMed ID: 12653481
[TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of human natural killer cells in mice with severe combined immunodeficiency inhibits growth of Hsp70-expressing tumors.
Multhoff G; Pfister K; Botzler C; Jordan A; Scholz R; Schmetzer H; Burgstahler R; Hiddemann W
Int J Cancer; 2000 Dec; 88(5):791-7. PubMed ID: 11072250
[TBL] [Abstract][Full Text] [Related]
4. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.
Krause SW; Gastpar R; Andreesen R; Gross C; Ullrich H; Thonigs G; Pfister K; Multhoff G
Clin Cancer Res; 2004 Jun; 10(11):3699-707. PubMed ID: 15173076
[TBL] [Abstract][Full Text] [Related]
5. The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells.
Gastpar R; Gross C; Rossbacher L; Ellwart J; Riegger J; Multhoff G
J Immunol; 2004 Jan; 172(2):972-80. PubMed ID: 14707070
[TBL] [Abstract][Full Text] [Related]
6.
Shevtsov M; Pitkin E; Ischenko A; Stangl S; Khachatryan W; Galibin O; Edmond S; Lobinger D; Multhoff G
Front Immunol; 2019; 10():454. PubMed ID: 30967859
[TBL] [Abstract][Full Text] [Related]
7. Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT Cells.
Hromadnikova I; Li S; Kotlabova K; Dickinson AM
PLoS One; 2016; 11(3):e0151535. PubMed ID: 26982331
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report.
Milani V; Stangl S; Issels R; Gehrmann M; Wagner B; Hube K; Mayr D; Hiddemann W; Molls M; Multhoff G
J Transl Med; 2009 Jun; 7():50. PubMed ID: 19549307
[TBL] [Abstract][Full Text] [Related]
9. Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells.
Stangl S; Gross C; Pockley AG; Asea AA; Multhoff G
Cell Stress Chaperones; 2008; 13(2):221-30. PubMed ID: 18759005
[TBL] [Abstract][Full Text] [Related]
10. The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands.
Elsner L; Muppala V; Gehrmann M; Lozano J; Malzahn D; Bickeböller H; Brunner E; Zientkowska M; Herrmann T; Walter L; Alves F; Multhoff G; Dressel R
J Immunol; 2007 Oct; 179(8):5523-33. PubMed ID: 17911639
[TBL] [Abstract][Full Text] [Related]
11. CAR T Cells Targeting Membrane-Bound Hsp70 on Tumor Cells Mimic Hsp70-Primed NK Cells.
Bashiri Dezfouli A; Yazdi M; Benmebarek MR; Schwab M; Michaelides S; Miccichè A; Geerts D; Stangl S; Klapproth S; Wagner E; Kobold S; Multhoff G
Front Immunol; 2022; 13():883694. PubMed ID: 35720311
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells.
Gastpar R; Gehrmann M; Bausero MA; Asea A; Gross C; Schroeder JA; Multhoff G
Cancer Res; 2005 Jun; 65(12):5238-47. PubMed ID: 15958569
[TBL] [Abstract][Full Text] [Related]
13. Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study.
Kokowski K; Stangl S; Seier S; Hildebrandt M; Vaupel P; Multhoff G
Strahlenther Onkol; 2019 Apr; 195(4):352-361. PubMed ID: 30747241
[TBL] [Abstract][Full Text] [Related]
14. Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II Trial.
Specht HM; Ahrens N; Blankenstein C; Duell T; Fietkau R; Gaipl US; Günther C; Gunther S; Habl G; Hautmann H; Hautmann M; Huber RM; Molls M; Offner R; Rödel C; Rödel F; Schütz M; Combs SE; Multhoff G
Front Immunol; 2015; 6():162. PubMed ID: 25926832
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues.
Vujanovic NL; Yasumura S; Hirabayashi H; Lin WC; Watkins S; Herberman RB; Whiteside TL
J Immunol; 1995 Jan; 154(1):281-9. PubMed ID: 7995947
[TBL] [Abstract][Full Text] [Related]
16. In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.
Baxevanis CN; Gritzapis AD; Papamichail M
J Immunol; 2003 Sep; 171(6):2953-9. PubMed ID: 12960319
[TBL] [Abstract][Full Text] [Related]
17. Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody.
Stangl S; Gehrmann M; Riegger J; Kuhs K; Riederer I; Sievert W; Hube K; Mocikat R; Dressel R; Kremmer E; Pockley AG; Friedrich L; Vigh L; Skerra A; Multhoff G
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):733-8. PubMed ID: 21187371
[TBL] [Abstract][Full Text] [Related]
18. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
19. The endogenous danger signals HSP70 and MICA cooperate in the activation of cytotoxic effector functions of NK cells.
Elsner L; Flügge PF; Lozano J; Muppala V; Eiz-Vesper B; Demiroglu SY; Malzahn D; Herrmann T; Brunner E; Bickeböller H; Multhoff G; Walter L; Dressel R
J Cell Mol Med; 2010 Apr; 14(4):992-1002. PubMed ID: 20569278
[TBL] [Abstract][Full Text] [Related]
20. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
Xun CQ; Thompson JS; Jennings CD; Brown SA
Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
